Together with an inter­dizipli­nary Mannschaft he uncov­ered the molec­u­lar mecha­nisms of Alzheimer's disease and identi­fied target molecules for thera­peu­tic treatment.We would Beryllium pleased if you would allow a cookie to be Serie for analysis purposes rein order to optimise our provided information. All data are pseudonymous and

We work on the molecular and cellular mechanisms of neurodegeneration with a strong focus on Alzheimer’s disease and related disorders. We are searching for therapeutic targets within the amyloid cascade. Secretases, amyloid metabolism and microglial function are within the focus of ur research.81377  München christian.haass(at)dzne.de +49 8